Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Erythropoietin Drug Market Share, Growth, Industry Major Players Forecast to 2027

Wednesday, November 23, 2016 6:35
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Intended Audience

  • Erythropoietin Drug manufacturers
  • Erythropoietin Drug suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities


Market Scenario:

Erythropoietin is a glycoprotein hormone synthesized by interstitial fibroblasts in the kidney. Erythropoietin controls and regulates the mechanism of production of red blood cells. Increasing number of patients suffering from anemic condition induced due to cancer, HIV and ESRD treatment, increasing commercialization of biosimilar. Increasing interest of custom manufacturing organizations are some of the factors responsible for the growth of the global Erythropoietin Drug Market.


Key Players for Erythropoietin Drug Market:

  • Amgen
  • Astra Zeneca
  • Biocon
  • Dr. Reddys Labs
  • Hospira
  • Incepta Pharmaceuticals
  • Intas Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • ProBiomed
  • Reliance Formulation
  • Roche
  • Serum Institute of India
  • Sun Pharmaceuticals
  • Teva VHB Life Sciences
  • Zydus Cadila Healthcare


Get a Sample Report @


The market for erythropoietin drug is growing and expected to continue its growth in near future. Increasing number of patients suffering from anemic condition induced due to cancer, HIV and ESRD treatment, increasing commercialization of biosimilars. Increasing interest of custom manufacturing organizations are some of the key factors driving the growth of the global erythropoietin drug market. However, high pricing of erythropoietin drugs are major restraints for the growth of the global erythropoietin drug market.  The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.



By Types

  • Biologics
  • Biosimilars


By Products

  • Epoietin-alfa
  • Epoietin-beta
  • Darbepoietin-alfa
  • Epoetin-zeta
  • Epoetin-omega


By Applications

  • End Stage Renal Disease
  • Cancer
  • HIV
  • Dialysis
  • Anemia


Taste the market data and market information presented through more than 70 market data tables and figures spread in 120 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Erythropoietin Drug Market Research Report- Forecast To 2027


Table of Content

1 Executive Summary

2 Scope of the Report

2.1 Market Definition

2.2 Scope of the Study

2.2.1 Research Objectives

2.2.2 Assumptions & Limitations

2.3 Markets Structure

3 Market Research Methodologies

3.1 Research Process

3.2 Secondary Research

3.3 Primary Research

3.4 Forecast Model

4 Market Landscape

4.1 Five Forces Analysis

4.1.1 Threat of New Entrants

4.1.2 Bargaining power of buyers

4.1.3 Threat of substitutes

4.1.4 Segment rivalry

4.2 Value Chain of Global Erythropoietin Drug Market

5 Industry Overview of Global Erythropoietin Drug Market       

5.1 Introduction

5.2 Growth Drivers

5.3 Impact analysis

5.4 Market Challenges

5.5 Impact analysis

6 Market Trends

6.1 Introduction

6.2 Growth Trends     

6.3 Impact analysis



Browse Full Report @


Regional Analysis of Erythropoietin Drug Market:

Globally North America is the largest market for erythropoietin drug. The North American market for erythropoietin drug is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Europe is the second-largest market for erythropoietin drug which is expected to grow at a CAGR of XX%. Asia pacific region is expected to be growing in erythropoietin drug market.


Related Report

Global Kyphosis Market Information, by type (Postural Kyphosis, Scheuermann’s Kyphosis, Congenital Kyphosis and others), by treatment (Physical Therapy, Combination Therapies, Kyphoplasty, Surgeries and others), by end user (Hospital, Clinics and others) – Forecast to 2022


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.



Akash Anand,

Market Research Future

+1 646 845 9312


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.